These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29879899)

  • 41. Modulation of HIV-1 replication by a novel RhoA effector activity.
    Wang L; Zhang H; Solski PA; Hart MJ; Der CJ; Su L
    J Immunol; 2000 May; 164(10):5369-74. PubMed ID: 10799900
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Roles of p-ERM and Rho-ROCK signaling in lymphocyte polarity and uropod formation.
    Lee JH; Katakai T; Hara T; Gonda H; Sugai M; Shimizu A
    J Cell Biol; 2004 Oct; 167(2):327-37. PubMed ID: 15504914
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interconnecting Flexibility, Structural Communication, and Function in RhoGEF Oncoproteins.
    Felline A; Belmonte L; Raimondi F; Bellucci L; Fanelli F
    J Chem Inf Model; 2019 Oct; 59(10):4300-4313. PubMed ID: 31490066
    [TBL] [Abstract][Full Text] [Related]  

  • 44. FAK, PDZ-RhoGEF and ROCKII cooperate to regulate adhesion movement and trailing-edge retraction in fibroblasts.
    Iwanicki MP; Vomastek T; Tilghman RW; Martin KH; Banerjee J; Wedegaertner PB; Parsons JT
    J Cell Sci; 2008 Mar; 121(Pt 6):895-905. PubMed ID: 18303050
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Localized suppression of RhoA activity by Tyr31/118-phosphorylated paxillin in cell adhesion and migration.
    Tsubouchi A; Sakakura J; Yagi R; Mazaki Y; Schaefer E; Yano H; Sabe H
    J Cell Biol; 2002 Nov; 159(4):673-83. PubMed ID: 12446743
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phosphorylation-mediated regulation of GEFs for RhoA.
    Patel M; Karginov AV
    Cell Adh Migr; 2014; 8(1):11-8. PubMed ID: 24589508
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polo-like kinase 1 triggers the initiation of cytokinesis in human cells by promoting recruitment of the RhoGEF Ect2 to the central spindle.
    Petronczki M; Glotzer M; Kraut N; Peters JM
    Dev Cell; 2007 May; 12(5):713-25. PubMed ID: 17488623
    [TBL] [Abstract][Full Text] [Related]  

  • 48. BCL6 suppresses RhoA activity to alter macrophage morphology and motility.
    Pixley FJ; Xiong Y; Yu RY; Sahai EA; Stanley ER; Ye BH
    J Cell Sci; 2005 May; 118(Pt 9):1873-83. PubMed ID: 15860730
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Knockdown of Trio by CRISPR/Cas9 suppresses migration and invasion of cervical cancer cells.
    Hou C; Zhuang Z; Deng X; Xu Y; Zhang P; Zhu L
    Oncol Rep; 2018 Feb; 39(2):795-801. PubMed ID: 29207149
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Trio GEF mediates RhoA activation downstream of Slit2 and coordinates telencephalic wiring.
    Backer S; Lokmane L; Landragin C; Deck M; Garel S; Bloch-Gallego E
    Development; 2018 Oct; 145(19):. PubMed ID: 30177526
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Optogenetic Control of RhoA to Probe Subcellular Mechanochemical Circuitry.
    Cavanaugh KE; Oakes PW; Gardel ML
    Curr Protoc Cell Biol; 2020 Mar; 86(1):e102. PubMed ID: 32031760
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The RhoGEF Trio: A Protein with a Wide Range of Functions in the Vascular Endothelium.
    Kempers L; Driessen AJM; van Rijssel J; Nolte MA; van Buul JD
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576329
    [TBL] [Abstract][Full Text] [Related]  

  • 53. LKB1 controls human bronchial epithelial morphogenesis through p114RhoGEF-dependent RhoA activation.
    Xu X; Jin D; Durgan J; Hall A
    Mol Cell Biol; 2013 Jul; 33(14):2671-82. PubMed ID: 23648482
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Signaling efficiency of Gαq through its effectors p63RhoGEF and GEFT depends on their subcellular location.
    Goedhart J; van Unen J; Adjobo-Hermans MJ; Gadella TW
    Sci Rep; 2013; 3():2284. PubMed ID: 23884432
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Echovirus 30 induced neuronal cell death through TRIO-RhoA signaling activation.
    Lee JW; Yeo SG; Kang BH; Lee HK; Kim JW; Lee SH; Kim KS; Cheon DS
    PLoS One; 2012; 7(5):e36656. PubMed ID: 22586486
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cancer-associated mutations in the protrusion-targeting region of p190RhoGAP impact tumor cell migration.
    Binamé F; Bidaud-Meynard A; Magnan L; Piquet L; Montibus B; Chabadel A; Saltel F; Lagrée V; Moreau V
    J Cell Biol; 2016 Sep; 214(7):859-73. PubMed ID: 27646271
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential RhoA dynamics in migratory and stationary cells measured by FRET and automated image analysis.
    Eichorst JP; Lu S; Xu J; Wang Y
    PLoS One; 2008; 3(12):e4082. PubMed ID: 19114999
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mapping the conformational mobility of multidomain proteins.
    Blackledge M
    Biophys J; 2010 May; 98(10):2043-4. PubMed ID: 20483310
    [No Abstract]   [Full Text] [Related]  

  • 59. Modeling Subcellular Protein Recruitment Dynamics for Synthetic Biology.
    Badu-Nkansah KA; Sernas D; Natwick DE; Collins SR
    Methods Mol Biol; 2023; 2553():189-207. PubMed ID: 36227545
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Receptor-Free Signaling at Curved Cellular Membranes.
    Ebrahimkutty MP; Galic M
    Bioessays; 2019 Oct; 41(10):e1900068. PubMed ID: 31483514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.